Skip to content

CeriBell, Inc. CBLL Net Investment in Lease

Net Investment in Lease at other companies

IAR
Integra LifeSciencesIART
ClearPoint Neuro logo
ClearPoint NeuroCLPT
Teladoc Health logo
Teladoc HealthTDOC
Kestra Medical Technologies, Ltd. Common Stock logo
Kestra Medical Technologies, Ltd. Common StockKMTS
Cerence Inc. logo
Cerence Inc.CRNC
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC

Other financials

Income statement

See full
Revenue$26.5M+29.3%
Gross profit$23.1M+28.4%
Operating income-$20.7M-46.0%
Net income-$19.7M-54.5%
EPS (diluted)-$0.52-44.4%

Balance sheet

See full
Cash & equivalents$45.3M-70.5%
Total debt$22.1M+1.6%
Total equity$140.8M-22.2%
Total assets$178.1M-16.6%

Cash flow

See full
Operating cash flow-$19.3M-69.2%
CapEx$125.0K-15.5%
Free cash flow-$19.4M-68.1%

Valuation

See full
Market cap$748.61M+15.6%
Enterprise value$725.47M+40.7%
P/S7.9×-1.2×

Profitability

See full
Gross margin87.7%+0.5pp
Operating margin-68.3%+5.5pp
Net margin-63.5%+1.0pp
FCF margin-52%-1.4pp

Returns & leverage

See full
Return on equity-37.5%
Debt / equity0.2×0.0×
Current ratio10.4×-6.9×

Where this comes from

Reported directly by CeriBell, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: CeriBell, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about CeriBell, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CeriBell, Inc.'s net investment in lease?
CeriBell, Inc. (CBLL) reported net investment in lease of $2.04M in Q1 2026.
How has CeriBell, Inc.'s net investment in lease changed year-over-year?
CeriBell, Inc.'s net investment in lease increased by 7.8% year-over-year, from $1.89M to $2.04M.
What is the long-term trend for CeriBell, Inc.'s net investment in lease?
Over 2 years (2023 to 2025), CeriBell, Inc.'s net investment in lease has grown at a 3.1% compound annual growth rate (CAGR), from $2.16M to $2.3M.